Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Prevalence of Hepatitis B virus genotypes in HBsAg positive individuals of Afghanistan

Authors: Sobia Attaullah, Saif ur Rehman, Sanaullah Khan, Ijaz Ali, Sajid Ali, Shahid Niaz Khan

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

The structural and functional differences between hepatitis B virus (HBV) genotypes are the mainstay to severity, complications, treatment and possibly vaccination against the virus. This study was conducted to determine the HBV genotypes in HBsAg positive patients of Afghanistan as no such large scale data available previously.

Methods

Two hundred and fourteen HBsAg-positive patients were included in this study. All patients were anti-HCV and anti-HIV negative. All the samples were confirmed for HBV DNA with nested PCR while HBV DNA positive samples were subjected to type specific PCR for HBV genotyping (A-F).

Results

Of the total samples, 168 (78.5%) were males and 46 (21.49%) females, aged ranged between 18 to 71 years. This study demonstrated that genotype D (35.67%) is the predominant genotype circulating in Afghani's population. Genotype C was observed in 32.16% followed by genotype A (19.30%), and genotype B (7.02%) while 6.07% of the individuals were not typed.

Conclusion

This study has shown a heterogeneous distribution of HBV genotypes. Further more, extensive studies are required to investigate genetic and geographical divergence and characteristics of the virus in the country, as no such large sample sized study has been carried out so far in this country.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dokanehiifard S, Bidmeshkipour A: Study of Hepatitis B Virus (HBV) Genotypes in Kermanshah Province, West of Iran. eJournal of Biological Sciences Volume 2009,1(1):113-120. Dokanehiifard S, Bidmeshkipour A: Study of Hepatitis B Virus (HBV) Genotypes in Kermanshah Province, West of Iran. eJournal of Biological Sciences Volume 2009,1(1):113-120.
2.
go back to reference Guirgis BSS, Abbas RO, Azzazy HME: Hepatitis B virus genotyping: current methods and clinical implications. International Journal of Infectious Diseases 2010, e941-e953. Guirgis BSS, Abbas RO, Azzazy HME: Hepatitis B virus genotyping: current methods and clinical implications. International Journal of Infectious Diseases 2010, e941-e953.
3.
go back to reference Zhu CT, Dong CL: Characteristics of general distribution of hepatitis B virus genotypes in China. Hepatobiliary Pancreat Dis Int 2009,8(4):397-401.PubMed Zhu CT, Dong CL: Characteristics of general distribution of hepatitis B virus genotypes in China. Hepatobiliary Pancreat Dis Int 2009,8(4):397-401.PubMed
4.
go back to reference Eftekhari Y, Arababadi MK, Hakimi H, Zarandi ER: Common HBV Genotype in Southeastern Iranian Patients. Arch Iran Med 2010,13(2):147-149.PubMed Eftekhari Y, Arababadi MK, Hakimi H, Zarandi ER: Common HBV Genotype in Southeastern Iranian Patients. Arch Iran Med 2010,13(2):147-149.PubMed
5.
go back to reference Khaled IAA, Mahmoud OM, Saleh AF, Baioumi EA: Prevalence of HBV Genotypes in Egypt among Hepatitis Patients. Journal of American Science 2010,6(11):185-190. Khaled IAA, Mahmoud OM, Saleh AF, Baioumi EA: Prevalence of HBV Genotypes in Egypt among Hepatitis Patients. Journal of American Science 2010,6(11):185-190.
6.
go back to reference Alam MM, Zaidi SZ, Malik SA, Shaukat S, Naeem A, Sharif S, Angez M, Butt JA: Molecular epidemiology of Hepatitis B virus genotypes in Pakistan. BMC Infect Dis 2007, 7: 115. 10.1186/1471-2334-7-115PubMedCentralCrossRefPubMed Alam MM, Zaidi SZ, Malik SA, Shaukat S, Naeem A, Sharif S, Angez M, Butt JA: Molecular epidemiology of Hepatitis B virus genotypes in Pakistan. BMC Infect Dis 2007, 7: 115. 10.1186/1471-2334-7-115PubMedCentralCrossRefPubMed
7.
go back to reference Understanding HIV in Afghanistan: the emerging epidemic and opportunity for prevention In A Desk Review of HIV in Afghanistan A combined effort of: The Islamic Republic of Afghanistan's National AIDS Control Program. The Johns Hopkins University, The Indian Institute of Health Management Research; 2008. Understanding HIV in Afghanistan: the emerging epidemic and opportunity for prevention In A Desk Review of HIV in Afghanistan A combined effort of: The Islamic Republic of Afghanistan's National AIDS Control Program. The Johns Hopkins University, The Indian Institute of Health Management Research; 2008.
8.
go back to reference ANSAF (Afghanistan National Strategic Framework for HIV/AIDS): National HIV/AIDS and STI Control Programme (2006-2010). Ministry of Public Health, Islamic Republic of Afghanistan; 2008. ANSAF (Afghanistan National Strategic Framework for HIV/AIDS): National HIV/AIDS and STI Control Programme (2006-2010). Ministry of Public Health, Islamic Republic of Afghanistan; 2008.
9.
go back to reference Todd CS, Ahmadzai M, Atiqzai F, Miller S, Smith JM, Ghazanfar SA, Strathdee SA: Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan. BMC Infect Dis 2008,17(8):119.CrossRef Todd CS, Ahmadzai M, Atiqzai F, Miller S, Smith JM, Ghazanfar SA, Strathdee SA: Seroprevalence and correlates of HIV, syphilis, and hepatitis B and C virus among intrapartum patients in Kabul, Afghanistan. BMC Infect Dis 2008,17(8):119.CrossRef
10.
go back to reference Todd CS, Abed AMS, Strathdee SA, Scott PT, Botros BA, Safi N, Earhart KC: Prevalence of HIV, hepatitis C, hepatitis B, and associated risk behaviors among injection drug users in Kabul, Afghanistan. Emerg Infect Dis 2007,13(9):1327-31.PubMedCentralCrossRefPubMed Todd CS, Abed AMS, Strathdee SA, Scott PT, Botros BA, Safi N, Earhart KC: Prevalence of HIV, hepatitis C, hepatitis B, and associated risk behaviors among injection drug users in Kabul, Afghanistan. Emerg Infect Dis 2007,13(9):1327-31.PubMedCentralCrossRefPubMed
11.
go back to reference Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Kim JH, Strathdee SA, Tjaden J: Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. Int J Drug Policy 2011,22(2):145-52. 10.1016/j.drugpo.2010.10.006CrossRefPubMed Nasir A, Todd CS, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Kim JH, Strathdee SA, Tjaden J: Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities. Int J Drug Policy 2011,22(2):145-52. 10.1016/j.drugpo.2010.10.006CrossRefPubMed
12.
go back to reference Todd CS, Nasir A, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J: HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS 2010, 24: S69-S75. 10.1097/01.aids.0000386736.25296.8dPubMedCentralCrossRefPubMed Todd CS, Nasir A, Stanekzai MR, Bautista CT, Botros BA, Scott PT, Strathdee SA, Tjaden J: HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan cities. AIDS 2010, 24: S69-S75. 10.1097/01.aids.0000386736.25296.8dPubMedCentralCrossRefPubMed
13.
go back to reference Kaya S, Cetin ES, Aridogan BC, Onal SN, Demirci M: Distribution of Hepatitis B Virus (HBV) Genotypes among HBV Carriers in Isparta. Iranian Biomedical Journal 2007,11(1):59-63.PubMed Kaya S, Cetin ES, Aridogan BC, Onal SN, Demirci M: Distribution of Hepatitis B Virus (HBV) Genotypes among HBV Carriers in Isparta. Iranian Biomedical Journal 2007,11(1):59-63.PubMed
14.
go back to reference Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan Z, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G: Distribution and Hepatocellular Carcinoma-Related Viral Properties of Hepatitis B Virus Genotypes in Mainland China: A Community-Based Study. Cancer Epidemiol Biomarkers Prevention 2009,19(3):777-86.CrossRef Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan Z, Gu C, Lu W, Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G: Distribution and Hepatocellular Carcinoma-Related Viral Properties of Hepatitis B Virus Genotypes in Mainland China: A Community-Based Study. Cancer Epidemiol Biomarkers Prevention 2009,19(3):777-86.CrossRef
15.
go back to reference Amini-Bavil-Olyaee S, Alavian SM, Adeli A, Sarrami-Forooshani R, Sabahi F: Hepatitis B virus genotyping, core promoter and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. Journal of Medical Virology 2006, 78: 358-364. 10.1002/jmv.20547CrossRefPubMed Amini-Bavil-Olyaee S, Alavian SM, Adeli A, Sarrami-Forooshani R, Sabahi F: Hepatitis B virus genotyping, core promoter and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. Journal of Medical Virology 2006, 78: 358-364. 10.1002/jmv.20547CrossRefPubMed
16.
go back to reference Baig S, Siddiqui A, Chakravarty R, Moatter T: Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Research Notes 2009, 2: 1. 10.1186/1756-0500-2-1PubMedCentralCrossRefPubMed Baig S, Siddiqui A, Chakravarty R, Moatter T: Hepatitis B virus subgenotypes D1 and D3 are prevalent in Pakistan. BMC Research Notes 2009, 2: 1. 10.1186/1756-0500-2-1PubMedCentralCrossRefPubMed
17.
go back to reference Jazayeri SM, Carman WF: Evolution of HBV Genotype D in the Middle East and South Asia. Hepatitis Monthly 2009,9(1):9-11. Jazayeri SM, Carman WF: Evolution of HBV Genotype D in the Middle East and South Asia. Hepatitis Monthly 2009,9(1):9-11.
18.
go back to reference Kurbanov F, Tanaka Y, Mizokami M: Geographical and genetic diversity of the human hepatitis B virus. Hepatology Research 2010, 40: 14-30. 10.1111/j.1872-034X.2009.00601.xCrossRefPubMed Kurbanov F, Tanaka Y, Mizokami M: Geographical and genetic diversity of the human hepatitis B virus. Hepatology Research 2010, 40: 14-30. 10.1111/j.1872-034X.2009.00601.xCrossRefPubMed
19.
go back to reference Mbayed AV, López JL, Telenta PFC, Palacios G, Badía I, Ferro A, Galoppo C, Campos R: Distribution of Hepatitis B Virus Genotypes in Two Different Pediatric Populations from Argentina. Journal of Clinical Microbiology 1998,3(11):3362-3365. Mbayed AV, López JL, Telenta PFC, Palacios G, Badía I, Ferro A, Galoppo C, Campos R: Distribution of Hepatitis B Virus Genotypes in Two Different Pediatric Populations from Argentina. Journal of Clinical Microbiology 1998,3(11):3362-3365.
20.
go back to reference Poustchi H, Mohamadnejad M, Malekzadeh R: Hepatitis B virus infection in Iran. Iranian Journal of Clinical Infectious Diseases 2007,2(1):37-51. Poustchi H, Mohamadnejad M, Malekzadeh R: Hepatitis B virus infection in Iran. Iranian Journal of Clinical Infectious Diseases 2007,2(1):37-51.
21.
go back to reference Wallace MR, Hale BR, Utz GC, Olson PE, Earhart KC, Thornton SA, Hyams KC: Endemic Infectious Diseases Of Afghanistan. Clin Infect Dis 2002,34(5):S171-S207. 10.1086/340704CrossRefPubMed Wallace MR, Hale BR, Utz GC, Olson PE, Earhart KC, Thornton SA, Hyams KC: Endemic Infectious Diseases Of Afghanistan. Clin Infect Dis 2002,34(5):S171-S207. 10.1086/340704CrossRefPubMed
Metadata
Title
Prevalence of Hepatitis B virus genotypes in HBsAg positive individuals of Afghanistan
Authors
Sobia Attaullah
Saif ur Rehman
Sanaullah Khan
Ijaz Ali
Sajid Ali
Shahid Niaz Khan
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-281

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine